Literature DB >> 18179452

Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.

S A Gonzalez1, C Zhang, M I Fiel, S Chung, L Zhang, I M Jacobson, A H Talal.   

Abstract

Although epidemiologic studies have documented that hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co-infected patients have accelerated fibrogenesis, especially those with CD4+ cell counts <200 cells/mm(3), the pathogenic mechanisms are poorly understood. We investigated whether severe immunodeficiency in co-infection is associated with changes in intrahepatic inflammatory cytokine mRNA levels. We measured interferon (IFN)-gamma, tumour necrosis factor-alpha, transforming growth factor (TGF)-beta(1), interleukin (IL)-4, IL-10, IL-12p35 and IL-12p40 mRNA levels by real-time PCR performed on liver samples from HCV mono-infected (n = 19) and HCV/HIV co-infected (n = 24) patients. Co-infected patients had decreased intrahepatic mRNA levels of IFN-gamma (P = 0.09), IL-4 (P = 0.05) and IL-12p35 (P = 0.04) compared with mono-infected patients, while IL-10 was increased (P = 0.07). In co-infected patients, IFN-gamma mRNA levels increased linearly with increasing peripheral CD4+ cell counts by 1.23 times relative to the calibrator for every 100 CD4+ cells/mm(3) increase (P = 0.02). No other cytokines were significantly associated with CD4+ cell counts. In conclusion, HIV-induced lymphopenia may result in hepatic inflammatory cytokine suppression in HCV/HIV co-infection. Intrahepatic IFN-gamma levels are significantly reduced in patients with advanced immunodeficiency. Further studies are needed to assess whether decreased IFN-gamma secretion by HCV-specific CD4+ cells may account for accelerated fibrogenesis in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18179452     DOI: 10.1111/j.1365-2893.2007.00949.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  8 in total

Review 1.  Antiretroviral treatment interruptions and risk of non-opportunistic diseases.

Authors:  Kenneth A Lichtenstein
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

Review 2.  The role of HIV in serious diseases other than AIDS.

Authors:  Andrew N Phillips; James Neaton; Jens D Lundgren
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

3.  Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

4.  Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.

Authors:  Jing Qin Wu; Monica Miranda Saksena; Vincent Soriano; Eugenia Vispo; Nitin K Saksena
Journal:  Virol J       Date:  2015-01-27       Impact factor: 4.099

5.  Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.

Authors:  Amanda Whitmill; Seongcheol Kim; Vivian Rojas; Fahad Gulraiz; Kazi Afreen; Mamta Jain; Meharvan Singh; In-Woo Park
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

6.  HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects.

Authors:  Sishun Hu; Marwan Ghabril; Tohti Amet; Ningjie Hu; Daniel Byrd; Kai Yang; Raj Vuppalanchi; Romil Saxena; Mona Desai; Jie Lan; Raymond Johnson; Samir Gupta; Naga Chalasani; Qigui Yu
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

7.  Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.

Authors:  Kaku A Armah; Emily K Quinn; Debbie M Cheng; Russell P Tracy; Jason V Baker; Jeffrey H Samet; Matthew S Freiberg
Journal:  BMC Infect Dis       Date:  2013-08-29       Impact factor: 3.090

Review 8.  Hepatitis C Virus and HIV Type 1 Co-Infection.

Authors:  Priyanka Gupta
Journal:  Infect Dis Rep       Date:  2013-06-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.